Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 22782150)

1.

Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma.

Singletary HL, Selim MA, Olsen E.

Arch Dermatol. 2012 May;148(5):572-4. doi: 10.1001/archdermatol.2011.1016. No abstract available.

PMID:
22782150
2.

Imiquimod 5%: a successful treatment for pseudolymphoma.

Baumgartner-Nielsen J, Lorentzen H.

Acta Derm Venereol. 2014 Jul;94(4):469. doi: 10.2340/00015555-1730. No abstract available.

3.

Treatment of cutaneous pseudolymphoma with interferon alfa-2b.

Tomar S, Stoll HL, Grassi MA, Cheney R.

J Am Acad Dermatol. 2009 Jan;60(1):172-4. doi: 10.1016/j.jaad.2008.07.052. No abstract available.

PMID:
19103377
4.

Postzoster cutaneous pseudolymphoma in a patient with B-cell chronic lymphocytic leukaemia.

Moreira E, Lisboa C, Azevedo F, Príncipe F, Lima M.

J Eur Acad Dermatol Venereol. 2007 Sep;21(8):1112-4. No abstract available.

PMID:
17714139
5.

[The hypereosinophilic syndrome].

Jegou J, Barete S, Frances C.

Ann Dermatol Venereol. 2003 Jun-Jul;130(6-7):664-6. French. No abstract available.

PMID:
13679710
6.

Interferon-alpha as first-line therapy for treatment of multicentric Castleman's disease.

Andrès E, Maloisel F.

Ann Oncol. 2000 Dec;11(12):1613-4. No abstract available.

7.

Childhood cutaneous lymphoid hyperplasia following feline scratches.

Madhogaria S, Carr RA, Gach JE.

Pediatr Dermatol. 2010 May-Jun;27(3):294-7. doi: 10.1111/j.1525-1470.2010.01142.x.

PMID:
20609149
8.

Cutaneous pseudolymphoma: an unusual eyelid presentation.

Cloke A, Lim LT, Crofts KP.

Semin Ophthalmol. 2012 Jan-Mar;27(1-2):35-6. doi: 10.3109/08820538.2011.622336.

PMID:
22352826
9.

The uncertain status of cutaneous pseudolymphoma.

Bachelez H.

Actas Dermosifiliogr. 2009 Nov;100 Suppl 1:33-7.

PMID:
20096195
10.

A case of cutaneous pseudolymphoma associated with silicone injection.

Lee MW, Choi JH, Sung KJ, Moon KC, Koh JK.

Acta Derm Venereol. 2004;84(4):312-3. No abstract available.

PMID:
15339080
11.

Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.

Zielińska W, Korczak-Rogoń A, Paszkiewicz J, Kowalik M, Cummins JM, Georgiades JA.

Arch Immunol Ther Exp (Warsz). 1996;44(5-6):359-66.

PMID:
9017152
12.

Cutaneus pseudolymphoma: a case report.

Dragonetti E, Cianchini G, Mastrangelo L, Mellone P, Baldi A.

In Vivo. 2004 Sep-Oct;18(5):549-51.

13.

What's your assessment? Cutaneous lymphoid hyperplasia.

Petros HM.

Dermatol Nurs. 2008 Oct;20(5):387-9. No abstract available.

PMID:
19051785
14.

[Variability and diagnostic limitations in cutaneous pseudolymphoma].

Bagot M.

Ann Dermatol Venereol. 2008 Nov;135(11):729-30. doi: 10.1016/j.annder.2008.07.011. Epub 2008 Aug 29. French. No abstract available.

PMID:
19061649
15.

Cutaneous pseudolymphoma occurring after traumatic implantation of a foreign red pigment.

Koh WL, Tay YK, Koh MJ, Sim CS.

Singapore Med J. 2013 May;54(5):e100-1.

PMID:
23716159
16.

Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma.

Mikasa K, Watanabe D, Kondo C, Tamada Y, Matsumoto Y.

J Am Acad Dermatol. 2005 Nov;53(5):911-2. No abstract available.

PMID:
16243162
17.

Guess what! Cutaneous lymphoid hyperplasia.

Gambichler T, Kreuter JA, Stücker M, Kobyletzki GV, Altmeyer P, Hoffmann K.

Eur J Dermatol. 2000 Dec;10(8):635-6. No abstract available.

PMID:
11125331
18.

Borrelial lymphocytoma cutis successfully treated with intralesional interferon-alpha-2A.

Aydogan K, Karadogan SK, Adim SB, Tunali S.

J Eur Acad Dermatol Venereol. 2006 Sep;20(8):1030-2. No abstract available.

PMID:
16922975
19.

Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.

Richardson SK, McGinnis KS, Shapiro M, Lehrer MS, Kim EJ, Vittorio CC, Junkins Hopkins JM, Rook AH.

J Cutan Med Surg. 2003 Jul-Aug;7(4 Suppl):8-12. No abstract available.

PMID:
12958701
20.

Erythrodermic CD8+ pseudolymphoma during infliximab treatment in a patient with psoriasis: use of cyclosporine as a rescue therapy.

Safa G, Luce K, Darrieux L, Tisseau L, Ortonne N.

J Am Acad Dermatol. 2014 Oct;71(4):e149-50. doi: 10.1016/j.jaad.2014.05.042. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk